Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis

Celik, I.; Demirel, G.; Oguz, S.; Uras, N.; Erdeve, ÖMER; Dilmen, U.

Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis

Celik I. H., Demirel G., Oguz S. S., Uras N., Erdeve Ö., Dilmen U.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.17, sa.6, ss.729-734, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17 Sayı: 6
Basım Tarihi: 2013
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.729-734
Anahtar Kelimeler: Newborn, Invasive fungal sepsis, Voriconazole, BIRTH-WEIGHT INFANTS, NEONATAL CANDIDIASIS, ANTIFUNGAL AGENTS, INFECTION
Ankara Üniversitesi Adresli: Evet

Özet

BACKGROUND: Invasive fungal sepsis has become the third most common cause of late-onset infections in many neonatal intensive care units (NICU). The prevalence rate ranges from 2.6% to 16.7% among very-low-birth-weight infants and from 5.5% to 20% among extremely low-birth-weight infants. Despite the development of several new antifungal agents in the past few years, the management of serious fungal infections in the newborn continues to be problematic.